CN100417723C - Lipase A variant of wild Bacillus subtilis and application thereof - Google Patents
Lipase A variant of wild Bacillus subtilis and application thereof Download PDFInfo
- Publication number
- CN100417723C CN100417723C CNB2006100668579A CN200610066857A CN100417723C CN 100417723 C CN100417723 C CN 100417723C CN B2006100668579 A CNB2006100668579 A CN B2006100668579A CN 200610066857 A CN200610066857 A CN 200610066857A CN 100417723 C CN100417723 C CN 100417723C
- Authority
- CN
- China
- Prior art keywords
- variant
- lipase
- gly
- bacillus subtilis
- asn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 41
- 101710098556 Lipase A Proteins 0.000 title claims abstract description 34
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 title claims abstract description 34
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 33
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 title claims abstract description 33
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 238000005406 washing Methods 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 241000894006 Bacteria Species 0.000 claims description 26
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 77
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 30
- 238000000034 method Methods 0.000 abstract description 22
- 125000000539 amino acid group Chemical group 0.000 abstract description 12
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract description 10
- 230000035772 mutation Effects 0.000 abstract description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 7
- 235000018102 proteins Nutrition 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 239000004471 Glycine Substances 0.000 abstract description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract description 4
- 235000003704 aspartic acid Nutrition 0.000 abstract description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 108090001060 Lipase Proteins 0.000 description 31
- 102000004882 Lipase Human genes 0.000 description 27
- 239000004367 Lipase Substances 0.000 description 26
- 235000019421 lipase Nutrition 0.000 description 26
- 102000004190 Enzymes Human genes 0.000 description 19
- 108090000790 Enzymes Proteins 0.000 description 19
- 238000012216 screening Methods 0.000 description 14
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 235000019626 lipase activity Nutrition 0.000 description 7
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 7
- 229940043267 rhodamine b Drugs 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 102200027714 rs62642946 Human genes 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical group CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 238000012207 quantitative assay Methods 0.000 description 3
- 102220023257 rs387907546 Human genes 0.000 description 3
- 102220023258 rs387907548 Human genes 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011942 biocatalyst Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- LVZSQWIWCANHPF-UHFFFAOYSA-N p-nitrophenyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 LVZSQWIWCANHPF-UHFFFAOYSA-N 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- GGIDEJQGAZSTES-UHFFFAOYSA-N (4-nitrophenyl) octanoate Chemical compound CCCCCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 GGIDEJQGAZSTES-UHFFFAOYSA-N 0.000 description 1
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004218 Orcein Substances 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- BXLYSRPHVMCOPS-ACZMJKKPSA-N Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO BXLYSRPHVMCOPS-ACZMJKKPSA-N 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011090 industrial biotechnology method and process Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000019248 orcein Nutrition 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- 150000007521 triprotic acids Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention discloses a wild bacillus subtilis lipase A variant and an application thereof, which has the purpose to provide a variant of wild bacillus subtilis lipase A, a sieving method and an application of the variant in the process of preparing a washing agent. The wild bacillus subtilis lipase A variant is protein obtained by one kind or several kinds of mutation combination in the following five kinds of mutation of an amino acid residue sequence of the wild bacillus subtilis lipase A: (1)No. 16 serine on the amino group end becomes proline by mutation; (2) No. 112 lysine becomes glutamic acid by mutation; (3) No. 142 alanine becomes serine by mutation; (4) No. 152 histidine becomes glutamine by mutation; (5) No. 153 glycine becomes aspartic acid by mutation. The present invention has high practical application value and wide market prospects.
Description
Technical field
The present invention relates to lipase Variant and application thereof, particularly relate to variant and screening method and its application in the preparing washing agent of wild Bacillus subtilis lipase A (BSLA).
Background technology
Lipase (Lipase) is widely regarded as a kind of very useful biological catalyst, not only can be used as detergent additives, food ingredient use, also can be used for numerous areas such as papermaking, production of biodiesel, organic synthesis.Wherein, the lipase A that comes from Bacillus subtillis (Bacillus subtilis 168) has multiple distinguished character (Dartois V., B., A., Schanck, K., Colson, C., Cloning, nucleotide sequenceand expression in Escherichia coli of a lipase gene from Bacillus subtilis168, BIOCHIMICA ET BIOPHYSICA ACTA, 1992,1131:253-260; Jaeger, K., S.Ransac, et al., Bacterial lipases, FEMS MICROBIOLOGY REVIEWS, 1994,15 (1): 29-63; Reetz, M., Lipases as practical biocatalysts, CURRENT OPINION IN CHEMICALBIOLOGY, 2002,6 (2): 145-150), comprising: 1) be one of lipase of minimum known today, its maturation protein (mature protein) only is made up of 181 amino-acid residues, and molecular weight is about 19kDa; 2) do not have lid (lid) structure, do not need the interface to activate (Interfacial activation); 3) fat with medium chain lipid acid is shown high reactivity; 4) optimum pH is 10.More than these characteristics, especially because the characteristics that do not need the interface to activate (interfacial activation) make the hydrolytic activity of this enzyme not rely on appropriate water-oil interface (or suitable water-content), and prevent and the combining of residual fat mols, the present inventor thinks that this lipase is expected to realize washing (first-wash) first in detergent industry very much, and can use it for foodstuffs industry or other industrial biotechnology field.
The orientation plan of enzyme is a kind of means that change the character of enzyme by the gene order that changes the enzyme molecule.Specifically, it is to evolve at the laboratory natural imitation.At first the gene of enzyme is carried out random mutation (technology commonly used has fallibility PCR (Error-prone PCR), DNA shuffle (DNA shuffling) etc.), make up the variant library; Secondly, select suitable carriers and host to express; At last the library is screened (screening) or selected (selection) to obtain the variant that character changes.And then be template with this variant, repeat said process, reach desired character until variant.At present, orthogenesis successfully has been used to change substrate activity, substrate specificity, thermostability, enantio-selectivity of enzyme etc., and obtained significant achievement (Kuchner, O., F.Arnold, Directed evolution of enzyme catalysts, TRENDS IN BIOTECHNOLOGY, 1997,15 (12): 523-530; Petrounia, I., F.Arnold, Designed evolution of enzymatic properties, CURRENT OPINION IN BIOTECHNOLOGY, 2000,11 (4): 325-33; Arnold, F., combinatorial and computational challenges for biocatalyst design, NATURE, 2001,409 (6817): 253-257).
Summary of the invention
The variant that the purpose of this invention is to provide wild Bacillus subtilis (Bacillus subtilis) lipase A with improvement enzymic activity.
Described variant is that the amino acid residue sequence with the wild Bacillus subtilis lipase A carries out the protein that obtains after one or more sudden change combinations in following five kinds of sudden changes: 1) Serine (S) from the 16th of aminoterminal (N end) sports proline(Pro) (P), is designated as S16P; 2) the 112nd Methionin (K) sports L-glutamic acid (E), is designated as K112E; 3) the 142nd arginine (R) sports Serine (S), is designated as R142S; 4) the 152nd Histidine (H) sports glutamine (Q), is designated as H152Q; 5) the 153rd glycine (G) sports aspartic acid (D), is designated as G153D; Described wild Bacillus subtilis lipase A has SEQ ID № in the sequence table: 1 amino acid residue sequence.
Wherein, preferred lipase A variant of wild Bacillus subtilis can have one of following amino acid residue sequences:
1) SEQ ID № in the sequence table: 2;
2) SEQ ID № in the sequence table: 3.
SEQ ID №: 2-3 forms by 181 amino-acid residues in the sequence table.To have SEQ ID № in the sequence table: the variant called after BSLA-1-4 of 2 amino acid residue sequence, this variant have above-mentioned S16P and two kinds of sudden changes of G153D simultaneously; To have SEQ ID № in the sequence table: the variant called after BSLA-2-6 of 3 amino acid residue sequence, this variant have above-mentioned S16P, K112E, R142S, H152Q and five kinds of sudden changes of G153D simultaneously.
The gene of above-mentioned lipase A variant of wild Bacillus subtilis of encoding also belongs to protection scope of the present invention, and wherein, preferred lipase A variant of wild Bacillus subtilis gene can be one of following nucleotide sequence:
1) SEQ ID № in the sequence table: 5;
2) SEQ ID № in the sequence table: 6.
SEQ ID №: 5-6 is by 543 based compositions in the sequence table, and above-mentioned lipase A variant of wild Bacillus subtilis BSLA-1-4 and BSLA-2-6 encode respectively.
Contain above-mentioned lipase A variant of wild Bacillus subtilis expression carrier, transgenic cell and host bacterium and also belong to protection scope of the present invention.
Another object of the present invention provides the method that a kind of screening has the active lipase Variant of high enzyme.
Screening method provided by the present invention may further comprise the steps:
1) the variant library of structure lipase gene;
2) the variant library is connected with carrier, the recombinant vectors that will carry the variant library then imports the host bacterium;
3) with step 2) transformant that obtains is inoculated in and carries out qualitative primary dcreening operation on the primary dcreening operation flat board, filters out the variant with lipase activity; Described primary dcreening operation is dull and stereotyped to add the marker that can filter out foreign vector on cultivating with the basis of solid medium in host bacterium routine, and the substrate of lipase;
4) the picking step 3) has the variant of lipase activity behind primary dcreening operation, it is inoculated in growth cultivates on the flat board, preserves as motherboard after growing single bacterium colony; Described growth is dull and stereotyped adds the marker that can filter out foreign vector on cultivating with the basis of solid medium in host bacterium routine;
5) bacterium colony on the step 4) motherboard is transferred to induce on the flat board induces with changeing embrane method; The described flat board of inducing adds the marker that can filter out foreign vector on cultivating with the basis of solid medium in host bacterium routine, and inductor;
6) cleavage step 5) in through the inductive bacterium colony, make the lipase of its expression be adsorbed on the surface of transfer film, transfer film is placed carry out qualitative multiple sieve on the multiple sieve flat board again, obtain the variant that improves than the wild-type lipase activity; Described multiple sieve is dull and stereotyped for only containing the flat board of the substrate of agarose and lipase;
7) activity of quantitative assay lipase Variant.
In above-mentioned screening method, can select for use any method of can be on a given lipase gene introducing sudden change randomly to make up lipase gene variant library in the described step 1), as fallibility PCR (Error-prone PCR), DNA shuffle (DNA shuffling) etc.
Step 2) carrier and host bacterium used in can be adopted any carrier and host bacterium that is applicable to lipase gene clone and expression in the biology field; Described carrier can be pET30a (+), pBR332, YEplac112, pRB473 etc.; The host bacterium can be e. coli bl21 (DE3), intestinal bacteria 5K, yeast 13bxV4, Bacillus subtillis MB216 etc.
The host bacterium difference of using, being used to prepare the dull and stereotyped selected solid medium of primary dcreening operation in the step 3) also may be different, is applicable to that such as the LB solid medium intestinal bacteria, YPD substratum are applicable to yeast etc.In addition, the marker that must determine to filter out foreign vector according to concrete used carrier and host bacterium, such as for the host bacterium that contains the plasmid of antibiotics resistance on those carriers and do not have this resistance, the host bacterium that can use this antibiosis usually to filter out to contain this plasmid, microbiotic commonly used is kantlex, penbritin, tsiklomitsin etc.For some auxotrophic host bacterium, then can select for use this nutritive substance to screen, for example to the yeast INVSc I of uridylic (Uracil) defective and contain uracil base because of plasmid pYES2, then can filter out the yeast INVSc I that contains plasmid pYES2 with uridylic.The substrate of lipase can be anyly can and easily judge the material whether this reaction takes place by lipase institute's catalysis.For example: colourless palmitinic acid p-nitrophenyl fat (p-nitrophenyl palmitate) is generated the xanchromatic p-NP behind the lipase hydrolysis; The material that sweet oil (Olive oil) is generated behind the lipase hydrolysis can be created on the compound that has fluorescent orange under the ultra violet lamp with orchil rhodamine B (Rhodamine B) reaction; Butyrin in solid medium (Tributyrin) can be formed transparent hydrolysis circle etc. behind the lipase hydrolysis.
Used transfer film can be any one film that can shift bacterium colony and adsorbed proteins, for example nitrocellulose filter, nylon membrane etc. in the step 5); Select suitable inductor according to concrete used carrier and host bacterium, as for the plasmid pET30a (+) that contains the T7 promotor, after this plasmid imports e. coli bl21 (DE3), (Isopropyl-β-D-thigalactopyranoside is IPTG) as inductor can to adopt isopropyl ss-D thiogalactoside.
Can adopt the bacterium colony cleavage method of any routine in the step 6), as contacting bacterium colony with the filter paper that contains lysate (as N,O-Diacetylmuramidase).
Can be in the step 7) with after in the variant liquid medium within that improves than the wild-type lipase activity that qualitative multiple sieve obtains, inducing in the step 6), its activity of quantitative assay.
The method that above-mentioned screening has the active lipase Variant of high enzyme is applicable to any one lipase, is particularly useful for the wild Bacillus subtilis lipase A.
The invention provides lipase A variant of wild Bacillus subtilis.The lipase activity determination result shows that this enzyme of lipase A variant of wild Bacillus subtilis of the present invention and wild-type compares, and the ratio of pNPP, pNPC and sweet oil is lived the highlyest can improve 4.8,3.0 and 2.6 times respectively.In conjunction with the kind specific character of the lipase of mentioning in the background technology, lipase A variant of wild Bacillus subtilis of the present invention has bigger advantage aspect the industrial preparation of washing composition.In addition, the screening method of lipase Variant of the present invention has simple to operate, and the advantage that the screening cycle is short easily realizes high flux screening.Based on above-mentioned advantage, the present invention has higher actual application value and vast market prospect.
Below in conjunction with specific embodiment the present invention is described in further details.
Description of drawings
Fig. 1 is the physical map of recombinant plasmid pET30a-BSLA
Fig. 2 is the crystalline structure of wild-type BSLA
Embodiment
Method therefor is ordinary method if no special instructions among the following embodiment, and concrete steps can be referring to " Molecular Cloning:A Laboratory Manual " (Sambrook, J., Russe11, David W., Molecular Cloning:A Laboratory Manual, 3
RdEdition, 2001, NY, Cold SpringHarbor).The primer is synthetic by Dalian precious biological (TakaRa) or the living worker in Shanghai.
The screening of embodiment 1, lipase A variant of wild Bacillus subtilis
Have the active lipase A variant of wild Bacillus subtilis of high enzyme with following method screening, detailed process may further comprise the steps:
1, the clone of wild Bacillus subtilis lipase A (BSLA) gene
Use Promega company
The genomic dna of Bacillus subtillis 168 (Bacillus subtilis 168) is extracted in Genomic DNA Purification test kit and the operation of reference reagent box specification sheets, be template with the genomic dna that is extracted then, at primer P1 (upstream primer): 5 '-AT
GAATTCATGGCTGAACACAATCCAGTCGTTATGG-3 ' (band underscore base is a restriction enzyme EcoRI recognition site) and primer P2 (downstream primer): 5 '-CCAGGGCG
AAGCTTUnder the guiding of TTCATTAATTCGTATTCTGG-3 ' (band underscore base is a restriction enzyme Hind III recognition site), with the method amplification Bacillus subtillis lipase A gene of Touch Down PCR, the Deep of NEB company is used in this PCR reaction
Archaeal dna polymerase, the PCR reaction conditions is: 94 ℃ of 2min of elder generation; 94 ℃ of 1min then, 62 ℃ of 1min, each circulation is successively decreased 0.5 ℃, 72 ℃ of 80sec, totally 21 circulations; 94 ℃ of 1min again, 52 ℃ of 1min, 72 ℃ of 80sec, totally 16 circulations; Last 72 ℃ of 10min.After reaction finishes, pcr amplification product is carried out 1% agarose gel electrophoresis detect, pcr amplification goes out the band of 575bp size as a result, conforms to expected results.Reclaim, this purpose fragment of purifying, with its with restriction enzyme EcoR I with (Novagen) be connected with plasmid pET30a (+) after Hind III carries out double digestion through same enzyme double digestion, to connect product electric shock transformed into escherichia coli Escherichia coliBL21 (DE3) competent cell, transformant is coated screening positive clone on the LB flat board that is added with 50 μ g/mL kantlex, extract plasmid, it is checked order, sequencing result shows correct (the SEQ ID № in the sequence table: 4) of the BSLA gene order of being cloned, and correctly be connected among the pET30a (+), with this recombinant plasmid called after pET30a-BSLA, its physical map as shown in Figure 1.
2, make up Bacillus subtillis lipase A variant library and import the host
Bacillus subtillis lipase A (BSLA) gene to step 1 clone carries out the fallibility pcr amplification, concrete grammar is: the recombinant plasmid that makes up with step 1 is a template, carry out the fallibility pcr amplification under the guiding of same primers as P1 and P2, the Taq of TaKaRa company is used in this PCR reaction
TMArchaeal dna polymerase, MnCl
2Concentration is 0.5mM, and the PCR reaction conditions is: 94 ℃ of 2min of elder generation; 94 ℃ of 1min then, 52 ℃ of 1min, 72 ℃ of 40sec, totally 30 circulations; Last 72 ℃ of 10min.After reaction finishes, pcr amplification product is carried out 1% agarose gel electrophoresis to be detected, the BSLA gene with sudden change of recovery, purifying pcr amplification, with its with restriction enzyme EcoR I with is connected with plasmid pET30a (+) after HindIII carries out double digestion through same enzyme double digestion, will connect product and shock by electricity among the importing intestinal bacteria Escherichia coli BL21 (DE3).
3, the screening enzyme BSLA variant that improves alive
1) qualitative primary dcreening operation
The conversion of step 2 there is the transformant of BSLA variant gene directly to coat to contain on the LB resistant panel of 50 μ g/mL kantlex, 10mg/L rhodamine B (Rhodamine B) and 31.25ml/L sweet oil (Olive oil) that (dull and stereotyped compound method is referring to Kouker, G., K.-E.Jaeger, Specific and Sensitive PlateAssay for Bacterial Lipases, APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1987,53 (1): 211-213), under 37 ℃, cultivate and carried out preliminary screening in 12-16 hour.
2) growth
The bacterium colony of the dots in red shape that the picking step 1) grows at flat board behind primary dcreening operation is inoculated in it on LB resistant panel that contains 50 μ g/mL kantlex, cultivates 3-4 hour down at 37 ℃, preserves as motherboard.
3) dull and stereotyped abduction delivering
Bacterium colony on the motherboard is transferred on the LB resistant panel that contains 50 μ g/mL kantlex and 0.5mM IPTG with nitrocellulose filter, under 30 ℃, induced 6 hours.
4) qualitative multiple sieve
With conventional cleavage method cracking somatic cells, the lipase of cell inner expression discharges by nitrocellulose filter and adsorbs.Then film is covered on the agarose plate that contains 10mg/L rhodamine B (Rhodamine B) and 31.25ml/L sweet oil (Oliveoil),, make the reaction of BSLA variant and sweet oil and rhodamine B 37 ℃ of warm down baths 10 hours.Take film then off, flat board is placed under the ultraviolet lamp observe, the bacterium colony that fluorescent orange is strong more represents that the activity of the lipase of wherein expressing is high more.
5) enzymic activity of quantitative assay BSLA variant
The picking fluorescent orange is better than the variant of wild-type BSLA, is inoculated in the LB liquid nutrient medium that contains 50 μ g/mL kantlex, adds 0.5mM IPTG, induces under 30 ℃ 6 hours, gathers in the crops 5 OD
600Cell, broken wall extracts intracellular enzyme, behind the purifying, lipase activity is carried out detection by quantitative (is contrast with wild-type BSLA), determines the highest active variant.So far, finished one and taken turns evolution.Then can be active the highest BSLA variant gene repeats above-mentioned steps 2 and step 3 as the template of fallibility PCR, carries out the evolution of a new round.
Wherein, the method for quantitatively determining of lipase activity is as follows:
Measure wild-type BSLA and variant thereof to palmitinic acid p-nitrophenyl fat (p-nitrophenyl palmitate, pNPP), sad p-nitrophenyl fat (p-nitrophenyl caprylate, pNPC), the activity of three kinds of substrates of sweet oil (olive oil).Activity measurement method to pNPP and pNPC sees document (Winkler for details, U.K., M.Stuckmann, Glycogen, Hyaluronate, and Some Other Polysaccharides GreatlyEnhance the Formation of Exolipase by Serratia marcescens, JOURNAL OFBACTERIOLOGY, 1979,138 (3): 663-670), active measuring method to sweet oil sees document (N.W.Tietz for details, E.A.Fiereck, A specific method for serum lipase determination, Clinica Chimica acta, 1966,13:352-359).Activity is defined as: under condition determination, the above-mentioned substrate of hydrolysis produces 1 μ mol in 1 minute p-NP (p-nitrophenol) or the needed enzyme amount of lipid acid (fatty acid) are defined as 1 activity unit.
After the result evolved in the first round, obtain an active the highest variant, called after BSLA-1-4, the amino acid residue sequence that changes body and be the wild Bacillus subtilis lipase A sports proline(Pro) (P) (being designated as S16P) from the Serine (S) of the 16th of aminoterminal (N end), and the 153rd glycine (G) is sported aspartic acid (D) (being designated as G153D), have SEQ ID № in the sequence table: 2 amino acid residue sequence, its nucleotides sequence of encoding is classified SEQ ID № in the sequence table as: 5.With this variant be template carry out second take turns evolution after, with the highest variant called after BSLA-2-6 of activity that obtains, this variant is that the amino acid residue sequence with the wild Bacillus subtilis lipase A sports proline(Pro) (P) (being designated as S16P) from the Serine (S) of the 16th of aminoterminal (N end), the 112nd Methionin (K) sports L-glutamic acid (E) (being designated as K112E), the 142nd arginine (R) sports Serine (S) (being designated as R142S), the 152nd Histidine (H) sports glutamine (Q) (being designated as H152Q), and the 153rd glycine (G) sported aspartic acid (D) (being designated as G153D), have SEQ ID № in the sequence table: 3 amino acid residue sequence, its nucleotides sequence of encoding is classified SEQ ID № as: 6.Wild-type BSLA and variant BSLA-2-6 live as shown in table 1 to the ratio of pNPP, pNPC and sweet oil, variant BSLA-2-6 has improved 4.8,3.0 and 2.3 times than wild-type BSLA respectively to the activity of pNPP, pNPC and sweet oil.
Table 1 wild-type BSLA and variant BSLA-2-6 live relatively for the ratio of pNPP, pNPC and sweet oil
The amino-acid residue of embodiment 2, lipase A variant of wild Bacillus subtilis is substituted in the position analysis in the three-dimensional structure
The amino-acid residue of the lipase A variant of wild Bacillus subtilis that embodiment 1 is obtained replaces and carries out the position analysis of three-dimensional structure.The crystalline structure of wild-type BSLA can obtain (ID:1ISP) from PDB, as shown in Figure 2, the amino acid of ball-and-stick model mark is the catalysis triprotic acid (Ser77, Asp133 and His156) of BSLA among the figure, and the position of 5 aminoacid replacement of lipase A variant of wild Bacillus subtilis of the present invention (S16, K112, R142, H152 and G153) uses club model mark respectively, and this several amino acid replacement all occurs in this enzyme surface.
Sequence table
<160>6
<210>1
<211>181
<212>PRT
＜213〉Bacillus subtillis (Bacillus subtilis)
<400>1
Ala?Glu?His?Asn?Pro?Val?Val?Met?Val?His?Gly?Ile?Gly?Gly?Ala?Ser
1 5 10 15
Phe?Asn?Phe?Ala?Gly?Ile?Lys?Ser?Tyr?Leu?Val?Ser?Gln?Gly?Trp?Ser
20 25 30
Arg?Asp?Lys?Leu?Tyr?Ala?Val?Asp?Phe?Trp?Asp?Lys?Thr?Gly?Thr?Asn
35 40 45
Tyr?Asn?Asn?Gly?Pro?Val?Leu?Ser?Arg?Phe?Val?Gln?Lys?Val?Leu?Asp
50 55 60
Glu?Thr?Gly?Ala?Lys?Lys?Val?Asp?Ile?Val?Ala?His?Ser?Met?Gly?Gly
65 70 75 80
Ala?Asn?Thr?Leu?Tyr?Tyr?Ile?Lys?Asn?Leu?Asp?Gly?Gly?Asn?Lys?Val
85 90 95
Ala?Asn?Val?Val?Thr?Leu?Gly?Gly?Ala?Asn?Arg?Leu?Thr?Thr?Gly?Lys
100 105 110
Ala?Leu?Pro?Gly?Thr?Asp?Pro?Asn?Gln?Lys?Ile?Leu?Tyr?Thr?Ser?Ile
115 120 125
Tyr?Ser?Ser?Ala?Asp?Met?Ile?Val?Met?Asn?Tyr?Leu?Ser?Arg?Leu?Asp
130 135 140
Gly?Ala?Arg?Asn?Val?Gln?Ile?His?Gly?Val?Gly?His?Ile?Gly?Leu?Leu
145 150 155 160
Tyr?Ser?Ser?Gln?Val?Asn?Ser?Leu?Ile?Lys?Glu?Gly?Leu?Asn?Gly?Gly
165 170 175
Gly?Gln?Asn?Thr?Asn
180
<210>2
<211>181
<212>PRT
＜213〉artificial sequence
<220>
<223>
<400>2
Ala?Glu?His?Asn?Pro?Val?Val?Met?Val?His?Gly?Ile?Gly?Gly?Ala?Pro
1 5 10 15
Phe?Asn?Phe?Ala?Gly?Ile?Lys?Ser?Tyr?Leu?Val?Ser?Gln?Gly?Trp?Ser
20 25 30
Arg?Asp?Lys?Leu?Tyr?Ala?Val?Asp?Phe?Trp?Asp?Lys?Thr?Gly?Thr?Asn
35 40 45
Tyr?Asn?Asn?Gly?Pro?Val?Leu?Ser?Arg?Phe?Val?Gln?Lys?Val?Leu?Asp
50 55 60
Glu?Thr?Gly?Ala?Lys?Lys?Val?Asp?Ile?Val?Ala?His?Ser?Met?Gly?Gly
65 70 75 80
Ala?Asn?Thr?Leu?Tyr?Tyr?Ile?Lys?Asn?Leu?Asp?Gly?Gly?Asn?Lys?Val
85 90 95
Ala?Asn?Val?Val?Thr?Leu?Gly?Gly?Ala?Asn?Arg?Leu?Thr?Thr?Gly?Lys
100 105 110
Ala?Leu?Pro?Gly?Thr?Asp?Pro?Asn?Gln?Lys?Ile?Leu?Tyr?Thr?Ser?Ile
115 120 125
Tyr?Ser?Ser?Ala?Asp?Met?Ile?Val?Met?Asn?Tyr?Leu?Ser?Arg?Leu?Asp
130 135 140
Gly?Ala?Arg?Asn?Val?Gln?Ile?His?Asp?Val?Gly?His?Ile?Gly?Leu?Leu
145 150 155 160
Tyr?Ser?Ser?Gln?Val?Asn?Ser?Leu?Ile?Lys?Glu?Gly?Leu?Asn?Gly?Gly
165 170 175
Gly?Gln?Asn?Thr?Asn
180
<210>3
<211>181
<212>PRT
＜213〉artificial sequence
<220>
<223>
<400>3
Ala?Glu?His?Asn?Pro?Val?Val?Met?Val?His?Gly?Ile?Gly?Gly?Ala?Pro
1 5 10 15
Phe?Asn?Phe?Ala?Gly?Ile?Lys?Ser?Tyr?Leu?Val?Ser?Gln?Gly?Trp?Ser
20 25 30
Arg?Asp?Lys?Leu?Tyr?Ala?Val?Asp?Phe?Trp?Asp?Lys?Thr?Gly?Thr?Asn
35 40 45
Tyr?Asn?Asn?Gly?Pro?Val?Leu?Ser?Arg?Phe?Val?Gln?Lys?Val?Leu?Asp
50 55 60
Glu?Thr?Gly?Ala?Lys?Lys?Val?Asp?Ile?Val?Ala?His?Ser?Met?Gly?Gly
65 70 75 80
Ala?Asn?Thr?Leu?Tyr?Tyr?Ile?Lys?Asn?Leu?Asp?Gly?Gly?Asn?Lys?Val
85 90 95
Ala?Asn?Val?Val?Thr?Leu?Gly?Gly?Ala?Asn?Arg?Leu?Thr?Thr?Gly?Glu
100 105 110
Ala?Leu?Pro?Gly?Thr?Asp?Pro?Asn?Gln?Lys?Ile?Leu?Tyr?Thr?SerIle
115 120 125
Tyr?Ser?Ser?Ala?Asp?Met?Ile?Val?Met?Asn?Tyr?Leu?Ser?Ser?Leu?Asp
130 135 140
Gly?Ala?Arg?Asn?Val?Gln?Ile?Gln?Asp?Val?Gly?His?Ile?Gly?Leu?Leu
145 150 155 160
Tyr?Ser?Ser?Gln?Val?Asn?Ser?Leu?Ile?Lys?Glu?Gly?Leu?Asn?Gly?Gly
165 170 175
Gly?Gln?Asn?Thr?Asn
180
<210>4
<211>543
<212>DNA
＜213〉Bacillus subtillis (Bacillus subtilis)
<400>4
gctgaacaca?atccagtcgt?tatggttcac?ggtattggag?gggcatcatt?caattttgcg 60
ggaattaaga?gctatctcgt?atctcagggc?tggtcgcggg?acaagctgta?tgcagttgat 120
ttttgggaca?agacaggcac?aaattataac?aatggaccgg?tattatcacg?atttgtgcaa 180
aaggttttag?atgaaacggg?tgcgaaaaaa?gtggatattg?tcgctcacag?catggggggc 240
gcgaacacac?tttactacat?aaaaaatctg?gacggcggaa?ataaagttgc?aaacgtcgtg 300
acgcttggcg?gcgcgaaccg?tttgacgaca?ggcaaggcgc?ttccgggaac?agatccaaat 360
caaaagattt?tatacacatc?catttacagc?agtgccgata?tgattgtcat?gaattactta 420
tcaagattag?atggtgctag?aaacgttcaa?atccatggcg?ttggacacat?cggccttctg 480
tacagcagcc?aagtcaacag?cctgattaaa?gaagggctga?acggcggggg?ccagaatacg 540
aat 543
<210>5
<211>543
<212>DNA
＜213〉artificial sequence
<220>
<223>
<400>5
gctgaacaca?atccagtcgt?tatggtccac?ggtattggag?gggcaccatt?caattttgcg 60
ggaattaaga?gctatctcgt?atctcagggc?tggtcgcggg?acaagctgta?tgcagttgat 120
ttttgggaca?agacaggcac?aaattataac?aatggaccgg?tattatcacg?atttgtgcaa 180
aaggttttag?atgaaacggg?tgcgaaaaaa?gtggatattg?tcgctcacag?catggggggc 240
gcgaacacac?tttactacat?aaaaaatctg?gacggcggaa?ataaagttgc?aaacgtcgtg 300
acgcttggcg?gcgcgaaccg?tttgacgaca?ggcaaggcgc?ttccgggaac?agatccgaat 360
caaaagattt?tatacacatc?catttacagc?agtgccgata?tgattgtcat?gaattactta 420
tcaagattag?atggtgctag?aaacgttcaa?atccatgacg?ttggacacat?cggccttctg 480
tacagcagcc?aagtcaacag?cctgattaaa?gaagggctga?acggcggggg?ccagaatacg 540
aat 543
<210>6
<211>543
<212>DNA
＜213〉artificial sequence
<220>
<223>
<400>6
gctgaacaca?atccagtcgt?tatggtccac?ggtattggag?gggcaccatt?taattttgcg 60
ggaattaaga?gctatctcgt?atctcagggc?tggtcgcggg?acaagttgta?tgcagttgat 120
ttttgggaca?agacaggcac?aaattataac?aatggaccgg?tattatcacg?atttgtgcaa 180
aaggttttag?atgaaacggg?tgcgaaaaaa?gtggatattg?tcgctcacag?catggggggc 240
gcgaacacac?tttactacat?aaaaaatctg?gacggcggaa?ataaagttgc?aaacgtcgtg 300
acgcttggcg?gcgcgaaccg?tttgacgaca?ggcgaggcgc?ttccgggaac?agatccgaat 360
caaaagattt?tatacacatc?catttacagc?agtgccgata?tgattgtcat?gaattactta 420
tcaagtttag?atggtgctag?aaacgttcaa?atccaggacg?ttggacacat?cggccttctg 480
tacagcagcc?aagtcaacag?cctgattaaa?gaagggctga?acggcggggg?ccagaatacg 540
aat 543
Claims (7)
1. lipase A variant of wild Bacillus subtilis is one of following aminoacid sequence:
1) the SEQ ID NO:2 in the sequence table;
2) the SEQ ID NO:3 in the sequence table.
2. the gene of coding claim 1 described lipase A variant of wild Bacillus subtilis.
3. gene according to claim 2 is characterized in that: described gene is one of following nucleotide sequence:
1) the SEQ ID NO:5 in the sequence table;
2) the SEQ ID NO:6 in the sequence table.
4. contain the described expression carrier of claim 2.
5. the transgenic cell that contains the described gene of claim 2.
6. the host bacterium that contains the described gene of claim 2.
7. the application of the described lipase A variant of wild Bacillus subtilis of claim 1 in the preparing washing agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100668579A CN100417723C (en) | 2006-03-31 | 2006-03-31 | Lipase A variant of wild Bacillus subtilis and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100668579A CN100417723C (en) | 2006-03-31 | 2006-03-31 | Lipase A variant of wild Bacillus subtilis and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1834236A CN1834236A (en) | 2006-09-20 |
| CN100417723C true CN100417723C (en) | 2008-09-10 |
Family
ID=37002133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100668579A Expired - Fee Related CN100417723C (en) | 2006-03-31 | 2006-03-31 | Lipase A variant of wild Bacillus subtilis and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100417723C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101838634B (en) * | 2010-05-25 | 2012-04-25 | 中国科学院武汉病毒研究所 | Bacillus subtilis lipase, preparation method and application |
| CN101857856B (en) * | 2010-05-25 | 2012-02-01 | 中国科学院武汉病毒研究所 | Bacillus subtilis lipase, and preparation method and application thereof |
| CN102851263B (en) * | 2011-07-01 | 2015-04-01 | 丰益(上海)生物技术研发中心有限公司 | High-throughout screening method of lipase gene mutation database and lipase mutation gene |
| CN102337253B (en) * | 2011-10-13 | 2017-08-22 | 浙江大学 | Polypeptide, polynucleotides, carrier and the host cell of separation |
| CN104450866B (en) * | 2014-10-24 | 2018-02-13 | 中国科学院广州能源研究所 | A kind of film trace high-throughput screening method of secreting type lipase gene engineering bacteria |
| CN109182299B (en) * | 2018-10-30 | 2021-12-31 | 福建师范大学 | Hydrogen peroxide-tolerant bacillus subtilis lipase mutant and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658871A (en) * | 1989-07-07 | 1997-08-19 | Lever Brothers Company, Division Of Conopco, Inc. | Microbial lipase muteins and detergent compositions comprising same |
| US6017866A (en) * | 1994-05-04 | 2000-01-25 | Genencor International, Inc. | Lipases with improved surfactant resistance |
| WO2004067705A2 (en) * | 2003-01-30 | 2004-08-12 | Council Of Scientific And Industrial Research | Stable lipase variants |
-
2006
- 2006-03-31 CN CNB2006100668579A patent/CN100417723C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658871A (en) * | 1989-07-07 | 1997-08-19 | Lever Brothers Company, Division Of Conopco, Inc. | Microbial lipase muteins and detergent compositions comprising same |
| US6017866A (en) * | 1994-05-04 | 2000-01-25 | Genencor International, Inc. | Lipases with improved surfactant resistance |
| WO2004067705A2 (en) * | 2003-01-30 | 2004-08-12 | Council Of Scientific And Industrial Research | Stable lipase variants |
Non-Patent Citations (6)
| Title |
|---|
| Cloning, nucleotide sequence and expression in Escherichia coli of a lipase gene from Bacillus subtilis 168. Veronique Dartois, Alain Baulard, Karin Schanck et al.Biochimica et Biophysica Acta,No.1131. 1992 |
| Cloning, nucleotide sequence and expression in Escherichia coli of a lipase gene from Bacillus subtilis 168. Veronique Dartois, Alain Baulard, Karin Schanck et al.Biochimica et Biophysica Acta,No.1131. 1992 * |
| 枯草杆菌脂肪酶的基因克隆、定向进化与非水酶学研究. 马吉胜，103-114. 2005 |
| 枯草杆菌脂肪酶的基因克隆、定向进化与非水酶学研究. 马吉胜，103-114. 2005 * |
| 脂肪酶和酯酶的定向进化及其应用. 刘艳莉，杨广宇，王秋岩等.生物加工过程，第4卷第1期. 2006 |
| 脂肪酶和酯酶的定向进化及其应用. 刘艳莉，杨广宇，王秋岩等.生物加工过程，第4卷第1期. 2006 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1834236A (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Couto et al. | Isolation of a novel lipase from a metagenomic library derived from mangrove sediment from the south Brazilian coast | |
| CN100417723C (en) | Lipase A variant of wild Bacillus subtilis and application thereof | |
| Zhang et al. | Cloning, expression, and characterization of a cold-adapted lipase gene from an antarctic deep-sea psychorotrophic bacterium, Psychobacter sp. 7195 | |
| Böhm et al. | Crystal structure of Klebsiella sp. ASR1 phytase suggests substrate binding to a preformed active site that meets the requirements of a plant rhizosphere enzyme | |
| Chessa et al. | Purification, physico-chemical characterization and sequence of a heat labile alkaline metalloprotease isolated from a psychrophilic Pseudomonas species | |
| CN107893060A (en) | A kind of marine bacteria source thermostabilization salt tolerant SGNH family's hydrolases and application | |
| US20120122184A1 (en) | Polypeptides of strain Bacillus sp. P203 | |
| CN107400666B (en) | A kind of aminopeptidase and its encoding gene and application | |
| Wang et al. | Isolation and characterization of a novel organic solvent-tolerant and halotolerant esterase from a soil metagenomic library | |
| CN105400750A (en) | Novel deep-sea low-temperature salt-tolerant esterase and application | |
| Musidlowska‐Persson et al. | Recombinant porcine intestinal carboxylesterase: cloning from the pig liver esterase gene by site‐directed mutagenesis, functional expression and characterization | |
| KR20050121667A (en) | Stable gene variants of lipases | |
| CN110004125A (en) | A kind of marine bacteria source development of new type alkali-resistant fibre organic solvent-resistant esterase and application | |
| CN111466511B (en) | Compositions containing a desepoxyprotease and methods of detoxification | |
| CN108359655A (en) | A kind of lipase mutant TDL-mut and its encoding gene that thermal stability is high | |
| CN111057691B (en) | Novel GDSL family lipid hydrolase EII-3 and encoding gene and application thereof | |
| CN101544982B (en) | Novel nucleic acid sequence of gamma-alcohol soluble protein gene and application thereof | |
| KR20110009863A (en) | A paenibacillus sp. hpl-002 strain for producing xylanase and an alkalic xylanase produced thereby and a producing method thereof | |
| Singh et al. | Overexpression and protein folding of a chimeric β-glucosidase constructed from Agrobacterium tumefaciens and Cellvibrio gilvus | |
| WO2001042432A2 (en) | Modified enzymatic activity through subdomain swaps between related alpha/beta-barrel enzymes | |
| CN112760306B (en) | Family six ester hydrolase with high salinity, organic solvent and detergent tolerance, and coding gene and application thereof | |
| CN113755474B (en) | Carboxypeptidase, and coding gene and application thereof | |
| CN1178835A (en) | Hear resisting basic phosphatase and its expression | |
| KR100578539B1 (en) | Phytase produced from Citrobacter braakii | |
| CN107189955A (en) | A kind of deep-sea Novel thermostable alkaline esterase and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080910 Termination date: 20150331 |
|
| EXPY | Termination of patent right or utility model |